Tandem Device Updater

Tandem Diabetes Care is the only company that allows its customers to remotely update the software of their in-warranty t:slim X2 insulin pump as additional features become available.*

With the t:slim X2™ insulin pump, you are investing in a pump that gets updated, not outdated. Pump updates are available for download from the comfort of your own home using a personal computer. Just complete any required online training and Tandem will provide instructions on how to access the Tandem Device Updater and complete the software update on your insulin pump.

Available Updates

Click on the software updates to learn more about eligibility, the features included, and how to start the update process. A computer and internet connection will be required for this software update process. If you completed your required online training, expect to receive an email within 72 hours with your Update ID. If you did not receive an Update ID and it has been at least 72 hours since submitting your training documentation, please contact Customer Benefits Support.

t:slim X2 Insulin Pump with Basal-IQ Technology

T:SLIM X2 INSULIN PUMP

Basal-IQ™ Technology Update

Basal-IQ Update

t:slim X2 Insulin Pump with Control-IQ Technology

T:SLIM X2 INSULIN PUMP

Control-IQ™ Technology Update

CONTROL-IQ Update

System Requirements

A computer and internet connection will be required to update your pump. Please take a minute to review the following technical requirements. In order to install the Tandem Device Updater software, you will need administrator rights on your computer.

Supported Operating Systems

Microsoft Windows 11
Microsoft Windows 10 (64 bit)
Microsoft Windows 8.1 (64 bit)
Mac OS Monterey (v.12.x)
Mac OS Big Sur (v.11.0.x)
Mac OS Catalina (v10.15.x)

Minimum Computer Requirements

1 GB RAM
1 GB of available disk space
x86 compatible 1.6 GHz processor
USB 2.0 port or later

Supported Devices

t:slim X2 insulin pump

* Additional feature updates are not currently available for the t:slim X2 insulin pump with Control-IQ technology. Control-IQ technology is available only to customers who reside in the United States or Canada, and other select geographies. Future updates for all or some of Tandem's products may not be developed and may not be offered everywhere, and would be subject to applicable regulatory approvals. Software updates are only available to customers who are in warranty at the time they update their pump. Additional training may be required to access certain future software updates. Charges may apply. Tandem may discontinue select software and features over time at its discretion.

Please review our Tandem Device Updater End User License Agreement, which applies exclusively to the download and use of the Tandem Device Updater, and our Tandem Device Updater Privacy Notice, which explains what data Tandem collects from you upon download and use of the Tandem Device Updater software.

Important Safety Information

The pump and each System below is indicated for use in individuals six years of age and greater. The pump and each System is intended for single user use. The pump and each System is indicated for use with NovoRapid or Humalog U-100 insulin.

The t:slim X2 insulin pump with Basal-IQ technology (the Basal-IQ System) consists of the t:slim X2 insulin pump, which contains Basal-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Basal-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Basal-IQ technology can be used to suspend insulin delivery based on CGM sensor readings.

The t:slim X2 insulin pump with Control-IQ technology (the Control-IQ System) consists of the t:slim X2 insulin pump, which contains Control-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Control-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Control-IQ technology can be used to automatically increase, decrease, and suspend delivery of basal insulin based on CGM sensor readings and predicted glucose values. The t:slim X2 insulin pump with Control-IQ technology can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The t:slim X2 insulin pump with Control-IQ technology is intended for the management of Type 1 diabetes.

Contraindications and Warning

WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 25 kilograms.

Do not use the t:slim X2 insulin pump with Control-IQ technology if using hydroxyurea. Neither System is indicated for use in pregnant women, people on dialysis, or critically ill users. Users of the pump and either System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts. The t:slim X2 pump and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.